Sarah has 15+ years of experience as a Medical Affairs leader, successfully leading the development and execution of Medical Affairs strategies and launch plans at both large and emerging life science companies, across a plethora of therapeutic areas. She brings substantial experience in lifecycle management, medical communications, publication planning, KOL engagement and evidence generation.

Prior to joining TGaS, Sarah had founded her own a consulting company designed to support pharmaceutical and biotech companies with pre-commercialization activities, including establishing Medical Affairs infrastructure, and leading strategic medical planning and execution of tactical goals to ensure successful product launches. She also oversaw Medical Affairs Strategy for the cardiovascular pipeline at MyoKardia/BMS and led the global Medical Affairs activities at Aquinox Pharmaceuticals.

Sarah has a degree in biochemistry from the University of Illinois, Urbana-Champaign and is the 2024 National President of Women In Bio (WIB).